The purpose of the Forum is to create a space for dialogue, to ensure the conversion of theory into practice, to increase international trust, to strengthen cooperation at all stages of the organization and conduct of clinical trials, to increase the level of the number and quality of clinical trials in Ukraine, taking into account the requirements of good clinical practice and international ethical principles of protection rights, security and well-being of the subjects under martial law.
The main attention will be paid to valuable experience as a factor in the development of innovative potential in conducting clinical trials.

Forum directions:

• Current challenges, exchange of views regarding the search for new solutions and ways to increase Ukraine’s investment attractiveness in the field of preclinical research and clinical trials.
• Processes of harmonization of regulatory support for preclinical study of medicinal products and conducting clinical trials in Ukraine – implementation of regulatory support for preclinical study of medicinal products and clinical trials in Ukraine in accordance with the best European and world practices.
• Ensuring the proper conduct of clinical trials of medicinal products in the conditions of martial law – peculiarities of the organization of examination of clinical trial materials; maintaining the continuity of processes; compliance with ethical and moral and legal principles for participants in clinical trials; monitoring of adverse reactions.
• Issues of protection of rights, safety and observance of ethical and moral-legal principles for participants in clinical trials under martial law.
• Regulation of expanded access programs – compassionate use of medicinal products in Ukraine.
• How to be in the trend and join medical and preventive facilities in which clinical trials are conducted.
• Results of clinical audits of clinical trials of medicinal products in Ukraine – assessment of the quality of conducting clinical trials of medicinal products in Ukraine.
• New approaches to the development of medicinal products, including preclinical studies, advanced European and world technologies in clinical trials, their evaluation for decision-making in the health care system of Ukraine.
• Problems and prospects of digitalization of clinical trial processes in Ukraine.